NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, and Navinci Diagnostics, leader of innovative in situ proximity ligation ...
NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the launch of its novel product Glysite™ Scout Glycan Screening Kits.
The new kit combines Vector’s validated lectins with Navinci’s in situ PLA technology to gain insights beyond protein expression The Glysite™ Explorer in situ PLA Glycan Detection Kit is a fully ...
Vector Laboratories has completed a $124 million cash buyout backed by Thompson Street Capital Partners and will begin an acquisition strategy to expand protein detection capabilities. Vector ...
Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced ...
Accomplished marketing leader to drive strategic growth and customer-first initiatives NEWARK, Calif. — Vector Laboratories, a manufacturing partner of reagents and critical components for the ...
NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results